Investors
Newsroom

Areas of Focus
Pipeline
Science & Innovation
Patients & Caregivers
About
- Leadership Team
- Corporate Governance
Careers
- Job Openings

Investors
Newsroom

Lab technicians examining samples

Lab technicians examining samples

Latest News and Events

Home /

Newsroom

Filter by

Year Published
- 2025
- 2024
- 2023
- 2022
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
- 2013
- 2012
- 2011

Selections

June 3, 2021

Arrowhead Pharmaceuticals Initiates Phase 2b Study of Investigational ARO-APOC3 for Treatment of Severe Hypertriglyceridemia

Read More

June 2, 2021

Arrowhead Pharmaceuticals to Participate in Upcoming Conferences

Read More

May 18, 2021

Arrowhead Earns $10 Million Option Exercise Fee

Read More

May 12, 2021

Arrowhead Pharmaceuticals to Participate in Upcoming Conferences

Read More

May 4, 2021

Arrowhead Pharmaceuticals Reports Fiscal 2021 Second Quarter Results

Read More

April 28, 2021

Arrowhead Announces Improvement in Fibrosis after ARO-AAT Treatment in Patients with Alpha-1 Liver Disease

Read More

April 16, 2021

Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results

Read More

April 15, 2021

Arrowhead Announces ARO-DUX4 as First Muscle Targeted RNAi Candidate Using TRiMTM Platform

Read More

March 1, 2021

Arrowhead Pharmaceuticals Files IND to Begin Phase 2b Study of ARO-APOC3 in Patients with Severe Hypertriglyceridemia

Read More

February 4, 2021

Arrowhead Pharmaceuticals Reports Fiscal 2021 First Quarter Results

Read More

1...16 17 18 19 20...55

Footer Navigation

Areas of Focus
Pipeline
Science & Innovation
Patients & Caregivers
About
Careers

Facebook
Instagram
LinkedIn
Twitter

Privacy Policy
Cookie Policy
Terms of Use
Sitemap
Contact Us

© 2025 Arrowhead Pharmaceuticals, Inc.